Abstract
Aim:
To investigate the effects of 1-oxoeudesm-11(13)eno-12,8a-lactone (OEL), a novel eudesmane-type sesquiterpene isolated from Aster himalaicus, on the cell cycle and apoptosis in human glioblastoma cells in vitro.
Methods:
Human malignant glioblastoma cell lines U87 and A172 were used. The cytotoxicity of OEL was examined using the MTT assay. Cell apoptosis was assessed with DAPI staining and flow cytometry. DNA damage was determined by measuring the phosphorylation of H2AX using immunofluorescence staining and Western blotting. Cell cycle profiles were measured with flow cytometry. The mRNA expression of p53 and p21Waf1/Cip1 was investigated using real-time PCR. The protein expression of γ-H2AX, caspase-9, caspase-3, p53, p21Waf1/Cip1, cyclin B1, and cdc2 was analyzed with Western blotting.
Results:
Treatment of the malignant glioblastoma cells with OEL inhibited the cell growth in dose- and time-dependent manners (the values of IC50 at 48 and 72 h were 29.5 and 16.99 μmol/L, respectively, in U87 cells; 7.2 and 9.5 μmol/L, respectively, in A172 cells). OEL (10–30μmol/L) induced apoptosis and G2/M phase arrest in both U87 and A172 cells. OEL induced the phosphorylation of cdc2, a G2/M phase cyclin-dependent kinase, and decreased the expression of cyclin B1 required for progression through the G2/M phase in U87 cells. The compound remarkably increased the phosphorylation of H2AX in U87 cells. Moreover, OEL increased the mRNA and protein levels of p53 and its target gene p21Waf1/Cip1 in U87 cells. The compound also induced p53 phosphorylation. Pretreatment with PFT-α, a specific inhibitor of p53 transcriptional activity, could partially reverse the inhibition of OEL on the viability of U87 and A172 cells.
Conclusion:
OEL suppresses the growth of human glioblastoma cells in vitro via inducing DNA damage, p53-mediated cell cycle arrest and apoptosis, thus warrants further studies as a lead compound of anti-glioblastoma drug.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Tabatabai G, Wick W, Weller M . Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach? Discov Med 2011; 11: 529–36.
Liu G, Black KL, Yu JS . Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination. Expert Rev Vaccines 2006; 5: 233–47.
Sakariassen PO, Immervoll H, Chekenya M . Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 2007; 9: 882–92.
Hu W, Kavanagh JJ . Anticancer therapy targeting the apoptotic pathway. Lancet Oncol 2003; 4: 721–9.
Pae HO, Oh GS, Choi BM, Seo EA, Oh H, Shin MK, et al. Induction of apoptosis by 4-acetyl-12,13-epoxyl-9-trichothecene-3,15-diol from Isaria japonica Yasuda through intracellular reactive oxygen species formation and caspase-3 activation in human leukemia HL-60 cells. Toxicol In Vitro 2003; 17: 49–57.
Li X, Zhao Y, Wu WK, Liu S, Cui M, Lou H . Solamargine induces apoptosis associated with p53 transcription-dependent and transcription-independent pathways in human osteosarcoma U2OS cells. Life Sci 2011; 88: 314–21.
Meng XW, Lee SH, Kaufmann SH . Apoptosis in the treatment of cancer: a promise kept? Curr OpinCell Biol 2006; 18: 668–76.
Reed JC . Apoptosis-targeted therapies for cancer. Cancer Cell 2003; 3: 17–22.
Jung MJ, Yoo YC, Lee KB, Kim JB, Song KS . Isolation of epi-oleanolic acid from Korean mistletoe and its apoptosis-lnducing activity in tumor cells. Arch Pharm Res 2004; 27: 840–4.
Kim S, Moon A . Capsaicin-induced apoptosis of H-ras-transformed human breast epithelial cells is Rac-dependent via ROS generation. Arch Pharm Res 2004; 27: 845–9.
Wang W, Bu B, Xie M, Zhang M, Yu Z, Tao D . Neural cell cycle dysregulation and central nervous system diseases. Prog Neurobiol 2009; 89: 1–17.
Wiseman LR, Markham A . Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer. Drugs 1996; 52: 606–23.
Perez EA . Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther 2009; 8: 2086–95.
Xie WD, Weng CW, Niu YF, Lai PX, Row KH . Eudesmane sesquiterpenes and other constituents from Aster himalaicus. Chem Biodivers 2010; 7: 221–4.
Dhar SK, St Clair DK . Nucleophosmin blocks mitochondrial localization of p53 and apoptosis. J Biol Chem 2009; 284: 16409–18.
Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR . p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 2000; 275: 7337–42.
Li X, Wu WK, Sun B, Cui M, Liu S, Gao J, et al. Dihydroptychantol A, a macrocyclic bisbibenzyl derivative, induces autophagy and following apoptosis associated with p53 pathway in human osteosarcoma U2OS cells. Toxicol Appl Pharmacol 2011; 251: 146–54.
Norbury CJ, Zhivotovsky B . DNA damage-induced apoptosis. Oncogene 2004; 23: 2797–808.
Rogakou EP, Boon C, Redon C, Bonner WM . Megabase chromatin domains involved in DNA double strand breaks in vivo. J Cell Biol 1999; 146: 905–16.
Elledge SJ . Cell cycle checkpoints: preventing an identity crisis. Science 1996; 274: 1664–72.
Wang Y, Ji P, Liu J, Broaddus RR, Xue F, Zhang W . Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy. Mol Cancer 2009; 8: 8.
Jacobs T . Control of the cell cycle. Dev Biol 1992; 153: 1–15.
Dash BC, El-Deiry WS . Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity. Mol Cell Biol 2005; 25: 3364–87.
Innocente SA, Abrahamson JL, Cogswell JP, Lee JM . p53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci U S A 1999; 96: 2147–52.
Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, et al. A p53-dependent mouse spindle checkpoint. Science 1995; 267: 1353–6.
Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S . Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39–85.
Cai Y, Lu J, Miao Z, Lin L, Ding J . Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biol Ther 2007; 6: 1794–9.
Yang J, Duerksen-Hughes P . A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis 1998; 19: 1117–25.
Israels ED, Israels LG . The cell cycle. Oncologist 2000; 5: 510–3.
Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–805.
Acknowledgements
This work was supported by grants from National Natural Science Foundation of China (No 81273532) and the Shandong Provincial Natural Science Foundation No 2009ZRB02091).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Ss., Wang, Yf., Ma, Ls. et al. 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro. Acta Pharmacol Sin 34, 271–281 (2013). https://doi.org/10.1038/aps.2012.137
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2012.137
Keywords
This article is cited by
-
Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth
Oncogene (2018)
-
Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27
Acta Pharmacologica Sinica (2014)
-
Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway
Acta Pharmacologica Sinica (2014)
